Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC100996578 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNASE4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FANCA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAG6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C20orf196 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RC3H2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC7A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF519 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBFOX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FNDC3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAAP20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on